Tuesday 27 February 2018

NEW PATENTS FEB 2018

New patents,

Sr no
Patent number
name
company
INDICATION
REMARKS, WAIT FOR STR TO APPEAR
1
WO-2018033631

MARIZOMIB
CELGENE
CANCER
Image result for MARIZOMIB
2
WO-2018034901

ELAMIPRETIDE
STEALTH
Barth syndrome; Mitochondrial myopathy
Elamipretide structure.svg
3
WO-2018033866

SACUBITRIL, VALSARTAN
NOVARTIS
CARDIAC FAILURE, HYPERTENSION
Image result for sacubitril and valsartan






4
WO-2018033149

OZANIMOD
CRYSTAL
Multiple sclerosis; Ulcerative colitis
Ozanimod.svg
5
WO-2018033139

SOFOSBUVIR
CHIA
Hepatitis C virus infection
Sofosbuvir.svg
6
WO-2018032521

LIRAGLUTIDE
SHENZEN

Non-insulin dependent diabetes; Obesity

Liraglutide.png
7
WO-2018032356
SOFOSBUVIR
PHARMARESOURCES
Hepatitis C virus infection
Sofosbuvir.svg
8
WO-2018032796

SITAFLOXACIN
CHEN-STONE
Bacterial infection
Sitafloxacin.png
9
WO-2018033939

BUDESONIDE
ANANTCO
Allergic rhinitis; Inflammatory bowel disease; Irritable bowel syndrome
Budesonid Grundstruktur V4.svg

 new patents,

Sr no
Patent number
name
company
INDICATION
REMARKS, WAIT FOR STR TO APPEAR
1
EP-03281941

LESINURAD
ZENTIVA

Gout; Hyperuricemia

Image result for LESINURAD
2
WO-2018029711
VENETOCLAX
MYLAN
Chronic lymphocytic leukemia
Venetoclax.svg
3
WO-2018029699

BELINIOSTAT
MSN
Hematological neoplasm; Solid tumor
Belinostat.svg






4
WO-2018029264

DAPAGLIFLOZIN
AMNEAL

Non-insulin dependent diabetes

Image result for DAPAGLIFLOZIN
5
WO-2018029223

GALETERONE
INDUSTRIALE
PROSTRATE TUMOR
Galeterone.svg
6

WO-2018028508

PIRFENIDONE
IND

Idiopathic pulmonary fibrosis

Pirfenidone2DACS.svg
7

WO-2018028506

PIRFENIDONE
IND

Idiopathic pulmonary fibrosis

Pirfenidone2DACS.svg
8
WO-2018029611

DAPAGLIFLOZIN
LAURUS

Non-insulin dependent diabetes

Image result for DAPAGLIFLOZIN
9
WO-2018028420

PLINABULIN
QUINGDAO
CANCER
Plinabulin.svg
10
WO-2018028679
MIRABEGRON
ZHEJIANG

Overactive bladder

Mirabegron.svg









No comments:

Post a Comment